Clinical trials: Lupus Nephritis

Lupus Nephritis

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

• Terminated
• Age: 18 to 75 years
• Phase 2
• Results posted

The purpose of this study is to evaluate the safety and effectiveness of BMS-986165 compared with placebo with regard to measures of kidney function in participants with lupus nephritis (LN).

Trial name

NCT03943147

Testing

BMS-986165, Mycophenolate Mofetil

Where

100 sites in United States, Australia and 14 more

Volunteers

16 people

Sponsor

Bristol-Myers Squibb